Health-Related Quality of Life in Metastatic, Hormone-Sensitive Prostate Cancer: ENZAMET (ANZUP 1304), an International, Randomized Phase III Trial Led by ANZUP.
J Clin Oncol
; 40(8): 837-846, 2022 03 10.
Article
in En
| MEDLINE
| ID: mdl-34928708
Full text:
1
Collection:
01-internacional
Health context:
6_ODS3_enfermedades_notrasmisibles
Database:
MEDLINE
Main subject:
Quality of Life
/
Prostatic Neoplasms, Castration-Resistant
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Prognostic_studies
Aspects:
Patient_preference
Limits:
Humans
/
Male
Language:
En
Journal:
J Clin Oncol
Year:
2022
Document type:
Article